As AI pervades biotech, what are investors looking for in 2023?

Six investors we surveyed recently told us that the macro environment has had a big impact on deal flow, valuations and M&A in biotech.

As AI pervades biotech, what are investors looking for in 2023? by Anna Heim originally published on TechCrunch